Artia Global Partners’s Pliant Therapeutics PLRX Stock Holding History

Artia Global Partners’s Portfolio PLRX Stock Details PLRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-50,000	Closed	-$538K	–	51
2024 Q2	$538K	Sell	50,000 -50,000	-50%	-$645K	0.1%	44
2024 Q1	$1.49M	Hold	100,000	–	–	0.3%	33
2023 Q4	$1.81M	Hold	100,000	–	–	0.53%	21
2023 Q3	$1.73M	Hold	100,000	–	–	0.72%	20
2023 Q2	$1.81M	Buy	+100,000	New	+$2.37M	0.62%	28

Other funds holding PLRX

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

BOCH

Blue Owl Capital Holdings New York $372M AUM 78.25% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

TGI

TRV GP IV Boston, Massachusetts $267M AUM 965.83% 1-Year Est. Return

Artia Global Partners's PLRX Position: Q3 2024 in Review

Artia Global Partners sold out of Pliant Therapeutics (PLRX) in Q3 2024, closing a stake of 50,000 shares — an estimated $538K sold.

Artia Global Partners first reported a position in PLRX in Q2 2023 and held it in 5 quarters. The position peaked at $1.81M in Q2 2023. 151 funds tracked by Wall St. Rank hold PLRX as of Q3 2024.

Artia Global Partners reported no remaining Pliant Therapeutics position as of Q3 2024 after selling out during the quarter.
Artia Global Partners sold 50,000 Pliant Therapeutics shares in Q3 2024, an estimated $538K.
Artia Global Partners first reported a position in Pliant Therapeutics in Q2 2023 and held it in 5 quarters.
Artia Global Partners's Pliant Therapeutics position peaked at $1.81M in Q2 2023.
151 funds tracked by Wall St. Rank held Pliant Therapeutics as of Q3 2024.

Based on Artia Global Partners's 13F filing for Q3 2024, filed 14 Nov 2024.